Karriereverlauf von Scott M. Storer
Ehemalige bekannte Positionen von Scott M. Storer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 28.11.2016 | 08.05.2018 |
| Treasurer | - | 08.05.2018 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - | - |
| BAXALTA INC | Corporate Officer/Principal | - | - |
Ausbildung von Scott M. Storer
| Kellogg School of Management | Masters Business Admin |
| University of Colorado Boulder | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Treasurer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Börse
- Insiders
- Scott M. Storer
- Erfahrung
